Abstract
Psychiatric medication discontinuation is common and can have negative impacts. Until recently, most research on discontinuation happened in an adherence/compliance framework. There is now recognition that discontinuation may be a desired goal for many individuals. The purpose of the present paper is to describe the results of a pioneering survey to explore professional support to service users during medication discontinuation to inform clinical practice and guide future research. Survey responses from 250 service users were summarized with regard to their use of prescriber and psychotherapy services during the process of discontinuing psychiatric medication. Only 65% of respondents reported seeing a prescriber and less than 50% reported seeing a psychotherapist while attempting to discontinue psychiatric medication. Combined with respondents’ answers describing the decision-making process and support received from these services, this paper identifies gaps in service and the need to improve providers’ ability to support individuals while they discontinue psychiatric medication.
Similar content being viewed by others
Change history
15 September 2022
Editor’s Note: Readers are alerted that data used in this article from openICSPR https://www.openicpsr.org/openicpsr/project/109272/version/V1/view/ is no longer available. A further editorial response will follow the resolution of this issue.
References
Carey, B. & Gebeloff, B. (2018). Many people taking antidepressants discover they cannot quit. The New York Times. http://www.nytimes.com
Chouinard, G., & Chouinard, V. A. (2008). Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychotherapy and Psychosomatics, 77(2), 69–77. https://doi.org/10.1159/000112883
Cohen, D., & Recalt, A. M. (2019). Discontinuing psychotropic drugs from participants in randomized controlled trials: A systematic review. Psychotherapy and Psychosomatics, 88(2), 96–104.
Dixon, L. B., Holoshitz, Y., & Nossel, I. (2016). Treatment engagement of individuals experiencing mental illness: Review and update. World Psychiatry, 15(1), 13–20.
Easter, A., Pollock, M., Pope, L. G., Wisdom, J. P., & Smith, T. E. (2015). Perspectives of treatment providers and clients with serious mental illness regarding effective therapeutic relationships. The Journal of Behavioral Health Services & Research, 43(3), 341–353. https://doi.org/10.1007/s11414-015-9492-5
El-Mallakh, P., & Findlay, J. (2015). Strategies to improve medication adherence in patients with schizophrenia: The role of support services. Neuropsychiatric Disease and Treatment, 11, 1077–1090. https://doi.org/10.2147/NDT.S56107
Fava, G. A. (2003). Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 64, 123–133.
Gibson, K., Cartwright, C., & Read, J. (2014). Patient-centered perspectives on antidepressant use. International Journal of Mental Health, 43(1), 81–99. https://doi.org/10.2753/IMH0020-7411430105
Gibson, K., Cartwright, C., & Read, J. (2016). ‘In my life antidepressants have been…’: A qualitative analysis of users’ diverse experiences with antidepressants. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0844-3
Green, C. A., Polen, M. R., Janoff, S. L., Castleton, D. K., Wisdom, J. P., Vuckovic, N., Perrin, N. A., Paulson, R. I., & Oken, S. L. (2008). Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. Psychiatric Rehabilitation Journal, 32(1), 9–22. https://doi.org/10.2975/32.1.2008.9.22
Gupta, S., & Cahill, J. D. (2016). A prescription for “deprescribing” in psychiatry. Psychiatric Services, 67(8), 904–907.
Hasson-Ohayon, I. (2018). Overlap and distinction between measures of insight and self-stigma. Psychiatric Research, 266, 47–64.
Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/10.1177/1049732318793418
Keisler-Starkey, K. & Bunch, L.N. (2020). Health insurance coverage in the United States: 2019. U.S. Census Bureau Current Population Reports, pp 60–271.
National Institute for Health and Care Excellence (NICE). (2009). Depression in adults: recognition and management. www.nice.org.uk/guidance/cg90.
Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health, 27(4), 322–328. https://doi.org/10.1080/09638237.2017.1370637
Ostrow, L., Croft, B., Weaver, A., & Naeger, S. (2019). An exploratory analysis of the role of social supports in psychiatric medication discontinuation: Results related to family involvement. Psychosis, 11(3), 212–222.
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017). Discontinuing psychiatric medications: A survey of long-term users. Psychiatric Services, 68(12), 1232–1238. https://doi.org/10.1176/appi.ps.201700070
Read, J., Cartwright, C., & Gibson, K. (2018). How many of 1829 antidepressant users report withdrawal effects or addiction? International Journal of Mental Health Nursing, 27(6), 1805–1815. https://doi.org/10.1111/inm.12488
Read, J., & Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176–186. https://doi.org/10.2174/1574886313666180605095130
Ride, J., Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., & Jacobs, R. (2019). Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness. Health Services Research, 54(6), 44.
Robiner, W. N., Tompkins, T. L., & Hathaway, K. M. (2019). Prescriptive authority: Psychologists’ abridged training relative to other professions’ training. Clinical Psychology: Science and Practice, 27(1), 58.
Roe, D., & Davidson, L. (2017). Noncompliance, nonadherence, and dropout: Outmoded terms for modern recovery-oriented mental health. Psychiatric Services, 68(10), 1076–1078. https://doi.org/10.1176/appi.ps.201600522
Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38–46. https://doi.org/10.2975/33.1.2009.38.46
Roe, D., Jones, N., Hasson-Ohayon, I., & Zisman-Ilani, Y. (2021). Conceptualization and study of antipsychotic medication use: From adherence to pattern of use. Psychiatric Services, 00, 1–3.
Russo, J. (2018). Through the eyes of the observed: Re-directing research on psychiatric drugs. Talking Point Papers, 3.
Salyers, M. P., & Zisman-Ilani, Y. (2020). Shared decision-making and self-directed care. In H. H. Goldman, R. G. Frank, & J. P. Morrissey (Eds.), The palgrave handbook of American mental health policy (pp. 197–228). Springer International Publishing.
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2018). Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Systematic Reviews, 7(1), 10. https://doi.org/10.1186/s13643-018-0676-y
Slade, M. (2017). Implementing shared decision making in routine mental health care. World Psychiatry, 16(2), 146–153.
Stanhope, V., Tondora, J., Davidson, L., Choy-Brown, M., & Marcus, S. C. (2015). Person-centered care planning and service engagement: a study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-015-0715-0
Stein, B. D., Kogan, J. N., Mihalyo, M. J., Schuster, J., Deegan, P. E., Sorbero, M. J., & Drake, R. E. (2013). Use of a computerized medication shared decision making tool in community mental health settings: Impact on psychotropic medication adherence. Community Mental Health Journal, 49(2), 185–192.
The International Early Psychosis Association writing Group. (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(suppl. 48), s120–s124.
Tobon, A. L., Flores, J. M., Taylor, J. H., Johnson, I., Landeros-Weisenberger, A., Aboiralor, O., Avila-Quintero, V. J., & Bloch, M. H. (2021). Racial implicit associations in psychiatric diagnosis, treatment, and compliance expectations. Academic Psychiatry, 45, 23–33.
White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management, and raising of awareness of, antidepressant withdrawal: Is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320981174
Zisman-Ilani, Y., Barnett, E., Harik, J., Pavlo, A., & O’Connell, M. (2017). Expanding the concept of shared decision making for mental health: Systematic search and scoping review of interventions. Mental Health Review Journal, 22(3), 191–213. https://doi.org/10.1108/MHRJ-01-2017-0002
Zisman-Ilani, Y., Lysaker, P. H., & Hasson-Ohayon, I. (2021). Shared risk taking: Shared decision making in serious mental illness. Psychiatric Services, 72(4), 461–463. https://doi.org/10.1176/appi.ps.202000156
Zisman-Ilani, Y., Roe, D., Elwyn, G., Kupermintz, H., Patya, N., Peleg, I., & Karnieli-Miller, O. (2019). Shared decision making for psychiatric rehabilitation services before discharge from psychiatric hospitals. Health Communication, 34(6), 631–637. https://doi.org/10.1080/10410236.2018.1431018
Zisman-Ilani, Y., Shern, D., Deegan, P., Kreyenbuhl, J., Dixon, L., Drake, R., Torrey, W., Mishra, M., Gorbenko, K., & Elwyn, G. (2018). Continue, adjust, or stop antipsychotic medication: Developing and user testing an encounter decision aid for people with first-episode and long-term psychosis. BMC Psychiatry, 18(1), 142.
Funding
The current study was not funded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
At the time of manuscript preparation, SN was an employee of Evidera and may have owned stock and/or stock options in the company. At present, SN is employed by Sanofi and may hold stock and/or stock options in the company. The authors declare no other conflicts of interest.
Informed consent
The study was reviewed and approved by the Institutional Review Board at Human Services Research Institute, and all participants provided informed consent. All authors certify responsibility for the current manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Darrow, S., Pelot, M., Naeger, S. et al. User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation. Community Ment Health J 58, 1416–1424 (2022). https://doi.org/10.1007/s10597-021-00933-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-021-00933-3